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MiR-150 is a microRNA (miRNA) specifically ex-
pressed in mature lymphocytes, but not their
progenitors. A top predicted target of miR-150
is c-Myb, a transcription factor controlling mul-
tiple steps of lymphocyte development. Com-
bining loss- and gain-of-function gene targeting
approaches for miR-150 with conditional and
partial ablation of c-Myb, we show that miR-
150 indeed controls c-Myb expression in vivo
in a dose-dependent manner over a narrow
range of miRNA and c-Myb concentrations and
that this dramatically affects lymphocyte devel-
opment and response. Our results identify a key
transcription factor as a critical target of a
stage-specifically expressedmiRNA in lympho-
cytes and suggest that this and perhaps other
miRNAs have evolved to control the expression
of just a few critical target proteins in particular
cellular contexts.
INTRODUCTION
B cell development and differentiation in mouse and man
are complex processes starting in fetal liver and bone mar-
row with the proliferative expansion of progenitor cells that
undergo sequential rearrangements of their antigen
receptor genes to produce a diverse, clonally selected
receptor repertoire. Cells expressing functional, nonself-
reactive receptors are then positively selected into the
peripheral pool of long-lived, mature B cells. This process
of positive selection can follow distinct pathways, de-
pending on environmental signals and, perhaps, proper-
ties of distinct classes of progenitor cells, to produce dis-
tinct subsets of mature, peripheral B cells. Major subsets
of mature B cells are follicular B cells, mainly localized in B
cell follicles in spleen and lymph nodes and responsible for146 Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc.classical, T cell-dependent (TD) antibody responses; mar-
ginal zone (MZ) B cells, localized in the marginal zone of
the spleen and known for their ability to respond rapidly
to infectious agents in the blood; and B1 cells, homing
to the peritoneal and pleural cavities and representing an
important source of ‘‘natural’’ antibodies in the blood as
an evolutionarily selected first line of defense against
pathogens. Follicular B and MZ B cells are also called
B2 cells (Hardy and Hayakawa, 2001; Berland and Wortis,
2002; Pillai et al., 2005).
Mature B cells are resting cells, whose numbers are
kept constant in a first approximation throughout life, al-
though there is a continuous influx of newcomers from
the bone marrow, at least in the case of follicular and
MZ B cells, and a continuous recruitment of cells into im-
mune responses. These responses involve activation by
antigen and various costimulatory molecules, cell prolifer-
ation, and differentiation into long-lived memory or termi-
nally differentiated, antibody secreting plasma cells
(Shapiro-Shelef and Calame, 2005).
It has become clear over the last decades that the var-
ious phases of B cell development and response are under
distinct programs of transcriptional control, which are
activated in the cells by environmental cues (Schebesta
et al., 2002). A large set of transcription factors participate
in this control together or in succession, and a key param-
eter in this interplay is their cellular concentrations, as
documented perhaps most strikingly in the context of lin-
eage commitment in early hematopoietic progenitors
(Laiosa et al., 2006; Laslo et al., 2006). Developmental pro-
cesses in the hematopoietc system and perhaps in gen-
eral may thus require rapid changes of transcription factor
concentrations, a requirement that could best be met
by mechanisms of posttranscriptional control. MiRNAs
have recently emerged as key factors in the posttranscrip-
tional control of intracellular protein concentrations in
metazoan organisms (Bartel, 2004). These 22 nt RNAs
can repress protein expression by specifically targeting
mRNAs for translational repression or degradation and
would thus appear ideally suited to control rapid changes
of protein concentrations in cells, as we expect them to be
required in hematopoietic development. Certain miRNAs
are indeed expressed in a stage-specific fashion in the
hematopoietic system (Chen et al., 2004; Monticelli et al.,
2005; Neilson et al., 2007), and emerging evidence sug-
gests that they can be involved in the control of lympho-
cyte development and function (Li et al., 2007; Thai
et al., 2007; Rodriguez et al., 2007).
We previously identified miR-150 as a miRNA selec-
tively expressed in mature, resting B and T cells, but not
their progenitors (Monticelli et al., 2005). A top predicted
target of miR-150 is the transcription factor c-Myb, which
we had previously shown to be critically important for mul-
tiple steps of lymphocyte development and required for
the generation of B1 cells (Bender et al., 2004; Thomas
et al., 2005). c-Myb is highly expressed in lymphocyte pro-
genitors, downregulated upon maturation, and again up-
regulated after activation of the mature cells. Combining
loss- and gain-of-function gene targeting approaches for
miR-150 with conditional and partial ablation of c-Myb,
we now show that miR-150 indeed controls c-Myb
expression in vivo, that this interaction quantitatively
explains the effect of ectopic miR-150 expression in B
cell progenitors, and that miR-150 ablation in the mouse
germline affects B cell response and subset differentiation
as would at least in part be predicted from deregulated
c-Myb expression. In a general way, these results support
the concept that the physiological function of a given
miRNA may lie in the control of the concentrations of just
a few critical target proteins in particular cellular contexts.
RESULTS
Stage-Specific Expression of MiR-150
during Lymphocyte Development
To study biological functions of miRNAs in lymphocyte
development, we searched for miRNAs specifically ex-
pressed in lymphocytes in a developmental stage-specific
manner, assuming that such miRNAs likely have lympho-
cyte-specific functions. By combining expression profiling
and northern blot analysis, we identified a few miRNAs
meeting this criterion (Monticelli et al., 2005). Among
them is miR-150, a miRNA that is highly expressed in ma-
ture and resting lymphocytes, but not in their progenitors
(Figure 1A). This stage-specific expression pattern sug-
gests that miR-150 may play a role in lymphocyte devel-
opment or function.
MiR-150 Targets the Transcription Factor c-Myb
To gain insights into the biological functions of miR-150,
we performed bioinformatics analyses to identify potential
targets, focusing on genes known to regulate lymphocyte
development. c-Myb, an essential transcription factor for
normal lymphocyte development (Bender et al., 2004;
Thomas et al., 2005), was among the top target genes pre-
dicted for miR-150 (Krek et al., 2005). In addition, miR-150
ranks the highest among all miRNAs possibly targeting
c-Myb (Tables S1 and S2 in the Supplemental Data avail-able with this article online). Interestingly, the pattern of
c-Myb expression in lymphocyte development is comple-
mentary to that of miR-150, in thatc-Myb ishighlyexpressed
in lymphocyteprogenitors, downregulateduponmaturation,
and upregulated again after activation of the mature cells
(Figure 1A) (Bender et al., 2004; Thomas et al., 2005).
To test whether miR-150 indeed targets c-Myb, we
performed reporter assays in cell culture and found that
miR-150 overexpression in HEK293T cells reduced by
a factor of seven the activity of a Renilla luciferase reporter
gene containing the wild-type c-Myb 30UTR, which har-
bors three putative miR-150 binding sites. In contrast, ex-
pression of the unrelated miR-191 had no significant effect
on the expression of this reporter (Figures 1B–1D). As a ref-
erence, the activity of a Renilla luciferase reporter gene
containing within its 30UTR two sites perfectly comple-
mentary to miR-150 was 11-fold reduced upon miR-150
expression (Figure 1D). To demonstrate that the effect of
miR-150 on the luciferase gene is dependent on the pres-
ence of the miR-150 binding sites, we generated a panel of
reporter constructs containing the c-Myb 30UTR with the
miR-150 binding sites mutated individually or in combina-
tion (Figure 1B). Although the mutation of site 1 did not in-
fluence the inhibitory effect of miR-150 on reporter gene
expression, mutation of sites 2 and 3 individually reduced
the inhibitory effect to 2.5- to 3-fold, and mutation of both
sites completely abolished the inhibitory effect, suggest-
ing that these two sites function cooperatively in mediat-
ing c-Myb inhibition (Figure 1E). A close examination of
these three sites revealed that only sites 2 and 3 are per-
fectly conserved across all mammals with genomic DNA
sequences available, whereas site 1 is not. These obser-
vations hold true also when comparing these sites within
a set of 12 metazoans, which include nonmammalian spe-
cies (D. Grun and N.R., unpublished data). Moreover, sites
2 and 3 align perfectly with miR-150 at nucleotide posi-
tions 1–8, whereas site 1 does not (Figure 1B). Thus, our
results confirm the idea that evolutionary conservation
and a perfect match at nucleotide positions 1–8 are good
indicators of functional miRNA binding sites (Lai, 2002;
Lewis et al., 2003; Doench and Sharp, 2004; Brennecke
et al., 2005; Xie et al., 2005; Krek et al., 2005) and establish
that c-Myb is indeed a functional target of miR-150.
MiR-150 Deficiency Leads to B1 Cell Expansion
and an Enhanced Humoral Immune Response
We have previously reported that B cell-specific deletion
of the c-Myb gene leads to a severe block of B cell devel-
opment at the pro- to pre-B transition and disappearance
of one of the mature B cell subsets, the so-called B1 cells
(Thomas et al., 2005). If miR-150 indeed targets c-Myb
in vivo, the predictions are that miR-150 deficiency will
lead to a phenotype opposite to that caused by the dele-
tion of c-Myb and that ectopic expression of miR-150 in B
cell progenitors will result in a block of B cell development.
We therefore used loss- and gain-of-function gene target-
ing approaches for miR-150 to study the functional inter-
play between miR-150 and c-Myb in vivo.Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc. 147
Figure 1. MiR-150 Regulates c-Myb Expression through Its 30UTR
(A) Expression of miR-150 and c-Myb during B and T cell development was determined by northern blot and western blot, respectively. The miR-150/
U6 ratio in CD8 T cells and the c-Myb/b-actin ratio in pro-B cells were arbitrarily set at 1.
(B) The c-Myb 30UTR contains three predicted miR-150 binding sites. Upper panel, alignment of the seed regions of the miR-150 sites with miR-150;
lower panel, the c-Myb 30UTR and its mutants. Numbers indicate positions of nucleotides. Crosses indicate the three-nucleotide mutation depicted in
the upper panel.
(C) A scheme of the psiCHECK2 reporter vector used in (D) and (E). Rluc, Renilla luciferase; Luc, firefly luciferase; and pA, polyadenylation signal.
(D) MiR-150 downregulates the expression of a reporter gene containing the c-Myb 30UTR. 2x mir150, two sites perfectly complementary to miR-150;
pCXN2, the vector used to transiently express miRNAs.
(E) Sites 2 and 3 mediate the inhibitory effect of miR-150 on the c-Myb 30UTR. The reporter assays in (D) and (E) were performed three times, with
essentially identical results. The Rluc/Luc ratio was arbitrarily set at 1 for all transfections with the empty pCXN2 vector, which was labeled as ‘‘vector’’
in (D) and ‘‘-’’ in (E).
Data are presented as mean ± SD in (D) and (E).
(F) Transient expression of miR-150 and miR-191 in HEK293T cells, as detected by northern blots. Numbers indicate the marker length in nucleotides.MiR-150 is encoded by an independent transcription
unit downstream of the genes encoding ribosomal pro-
teins L13a (Rpl13a) and S11 (Rps11) (UCSC Genome
Browser [http://genome.ucsc.edu/cgi-bin/hgGateway]
and Figure 2A). We deleted a 679 bp miR-150-coding re-
gion by introducing loxP sites for Cre-mediated recombi-
nation at both ends (Figure 2A). Breeding to deleter-cre
mice (Schwenk et al., 1995), which express Cre recombi-
nase early during embryogenesis, led to deletion of the
miR-150-coding region and the pGK-Neo drug selection148 Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc.marker in the germline and the complete absence of
miR-150 in homozygous mutant mice (mir150/ mice)
(Figures 2A and 2B).
Mir150/ mice were viable, fertile, and morphologically
normal. The development of T cells, follicular B cells, and
MZ B cells was also normal (data not shown). However,
in striking contrast to mice with a B cell-specific deletion
of c-Myb (in which B1 cells are absent), splenic B1 cells
were expanded 4-fold in number. In the peritoneal cavity,
B1 cells were expanded in number by a factor of 2, with a
Figure 2. Deficiency of MiR-150 Causes B1 Cell Expansion
(A) Generation of mir150/ mice by homologous recombination. A 679 bp miR150 encoding region together with a pGK-Neo cassette inserted next
to it were flanked by loxP sites, and both were removed in the mouse germline by breeding heterozygous mice to deleter-Cre mice.
(B) Detection of miR-150 in wild-type and mutant mice by northern blot analysis of spleen, mesenteric lymph node (mLN), and thymus.
(C and D) B1 cell expansion in the spleen and peritoneal cavity of mir150/ mice, examined at the age of 6–10 weeks. Each dot in (D) represents one
mouse examined. KO, mir150/; WT, wild-type. Bars indicate mean values.Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc. 149
Figure 3. Enhanced Humoral Immune Responses in mir150/ Mice
(A) Changes of miR-150 levels in B cells upon activation. Purified B cells pooled from ten B6 mice were activated in vitro with indicated stimuli for the
indicated time, and miR-150 and U6 levels were determined by northern blots. Twenty micrograms of total RNA was used for each sample. The
reduction in miR-150 and U6 abundance was partly due to increased RNA content in activated B cells.
(B) Enhanced upregulation of c-Myb in activated mir150/ B cells. Purified B cells pooled from five mice per genotype were activated in vitro with
10 mg/ml anti-IgM for the indicated time. c-Myb, Bcl2, and b-actin levels were determined by western blot. Asterisks indicate nonspecific bands. The
c-Myb/b-actin and Bcl2/b-actin ratio in activated mir150+/+ B cells at day 2 was arbitrarily set at 1.
(C) Cell-cycle analysis of in vitro-activated B cells as described in (B). Note that themir150/ culture contained less dead cells (Sub-G0) on day 3. Five
wild-type and six mir150/ mice were analyzed, with similar results.
(D) Increased serum immunoglobulin levels in unimmunized mir150/ mice. Fifteen mice per genotype were bled at the age of 8–10 weeks, and
serum Ig levels were determined by ELISA.
(E) Enhanced T-dependent response in mir150/ mice. Six mir150/ mice and nine wild-type mice were immunized with 5 mg alum-precipitated
NP36-CGG intraperitoneally at the age of 10 weeks and bled at the indicated time points. The levels of NP-specific Ig were determined by ELISA.
Bars indicate geometric mean values in (D) and (E).reciprocal reduction in peritoneal B2 cells (Figures 2C
and 2D). The B1 cells in both spleen and peritoneal cavity
were CD19+B220loCD5+CD43+CD23 (Figure 2C; data
not shown) and are, therefore, B1a cells (Berland and
Wortis, 2002).
Does miR-150 deficiency lead to c-Myb upregulation in
the various lymphocyte subsets? Western blot analysis of
purified B1a cells from peritoneal cavity, B2 cells, and CD4
T cells from spleen and peripheral lymph nodes showed
that c-Myb protein levels were too low to be detectable
in these cells from both mir150/ and wild-type mice150 Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc.(Figure S1A). This is probably due to control of c-Myb
gene expression at the transcriptional level, consistent
with previous reports that low c-Myb messenger RNA
(mRNA) levels were found in mature lymphocytes (Pauza,
1987; Golay et al., 1992; Bender et al., 2004; Thomas
et al., 2005). However, c-Myb mRNA is induced upon B
and T cell activation and peaks at 32–48 hr after stimula-
tion (Pauza, 1987; Golay et al., 1992), when a significant
amount of miR-150 is still present and could modulate
c-Myb protein levels (Figure 3A). Indeed, the induction of
c-Myb protein in mir150/ B cells upon IgM crosslinking
was enhanced by a factor of 2.6, compared to controls
(Figure 3B). A similar enhancement of c-Myb protein in-
duction was observed when mir150/ CD4 T cells were
activated (Figure S1B). This strongly suggests that miR-
150 directly controls c-Myb expression in vivo, in accord
with the reporter assays depicted in Figure 1. Given the
dependence of the B1 subset on c-Myb (Thomas et al.,
2005) and indeed its precise dosage (see below, Figure 6),
it seems likely, therefore, that the increased number of B1
cells in miR-150-deficient mice is due to deregulated
c-Myb expression at some stage of development involv-
ing activation of these cells.
B1 cells have been shown to produce a significant frac-
tion of the ‘‘natural’’ antibodies in the blood (Forster and
Rajewsky, 1987; Kroese et al., 1989; Fagarasan et al.,
2000). We therefore examined the serum immunoglobulin
(Ig) levels in mir150/ mice to search for functional con-
sequences of the expansion of B1 cells. Strikingly, the mu-
tant animals exhibited a 9-fold increase in IgA, a 3-fold
increase in IgG1, a 4-fold increase in IgG2b, and a 2-fold
increase in IgM serum levels (Figure 3D). The dramatic
increase in serum IgA levels is particularly intriguing, be-
cause in vitro class switch experiments have demon-
strated that B1 cells switch eight times more efficiently
from IgM to IgA production than follicular B cells (Kaminski
and Stavnezer, 2006). It is quite possible, however, that
some of the enhancement of the serum immunoglobulin
levels seen in the miR-150-deficient animals is due to
enhanced responses of follicular B cells as well. Indeed,
when miR-150 knockout mice were immunized with a T
cell-dependent (TD) antigen, they produced three to four
times more IgG1 antibodies than the controls (Figure 3E).
TD antibody responses are typically produced by follicular
B cells, not B1 cells. Enhanced c-Myb induction upon IgM
crosslinking could contribute to both the observed in-
crease in steady-state serum immunoglobulin levels and
the enhanced TD response in the mutant animals, as
higher c-Myb levels may promote the survival of activated
B cells. c-Myb has been previously reported to promote
lymphocyte survival by upregulating the prosurvival pro-
tein Bcl2 (Taylor et al., 1996; Salomoni et al., 1997). In-
deed, in cell culture experiments, we observed a modest
increase of Bcl2 protein levels in activated mir150/ B
cells on day 2 and a corresponding reduction in cell death
as determined by measuring DNA content on day 3 after
IgM crosslinking (Figures 3B and 3C), while proliferation
and class switch recombination of B2 cells were normal
(Figures SF2 and SF3).
Ectopic MiR-150 Expression Impairs
Lymphocyte Development
Having shown that miR-150 represses c-Myb protein
levels in vivo and mir150/ mice display a phenotype op-
posite to that caused by ablation of c-Myb in the B cell lin-
eage, we reasoned that ectopic expression of miR-150 in
B cell progenitors would result in downregulation of c-Myb
protein levels and a block in B cell development similar to
that caused by B cell-specific deletion of c-Myb (Thomaset al., 2005). This would also give us the opportunity to
study the quantitative aspects of miRNA-target gene inter-
action by genetically manipulating the levels of the miRNA.
To test this idea, we inserted a genomic DNA fragment
encoding miR-150, preceded by the synthetic CAG pro-
moter and a loxP-flanked Neo-STOP cassette, into the
ubiquitously expressed Rosa26 locus (Figure 4A). An frt-
flanked IRES-EGFP cassette was placed between the
mir150 genomic DNA fragment and the polyadenylation
signal (pA). Upon Cre-mediated excision of the Neo-
STOP cassette (Schwenk et al., 1995), the CAG promoter
drives the production of both miR-150 and EGFP in all
cells and tissues examined (Figure 4B and Figure S4).
We termed this mutant allelemir150-EGFP Tg. Ectopic ex-
pression of miR-150 inmir150-EGFP Tg thymocytes (used
for convenience because of their low levels of endoge-
nous miR-150 and their availability in large numbers)
was 23% of the endogenous level in naive CD4 T cells,
and expression almost doubled (to 43%) in mir150-
EGFP Tg/Tg thymocytes. miR-150 expression was in the
same range in bone marrow pro-B cells cultured in vitro
(see below, Figure 5C). Deletion of the IRES-EGFP cas-
sette by Flpe (the resulting allele termedmir150 Tg) (Rodri-
guez et al., 2000) resulted in slightly increased miR-150
expression (30% in mir150 Tg and 55% in mir150 Tg/Tg
thymocytes; Figures 4C and 4E). These results demon-
strate that in this experimental model the transgenic
miRNA is expressed at moderate levels, below those of
endogenous miR-150 in mature lymphocytes under phys-
iological conditions. This is important, as we aimed at
establishing a system of ectopic expression, not over-
expression. When c-Myb protein levels were measured
in thymocytes expressing different levels of miR-150, the
average c-Myb protein levels were 70% in mir150-EGFP
Tg/Tg and 65% in mir150 Tg/Tg thymocytes, compared
to 100% in wild-type thymocytes, indicating that ectopic
miR-150 expression reduces c-Myb protein levels in
a dose-dependent manner (Figures 4D and 4E).
Mice ectopically expressing miR-150 were viable, fer-
tile, and morphologically normal, but B cell development
was dramatically impaired. There was also an impairment
of T cell development, but this was less pronounced. We
therefore focus in this paper mainly on the B cell lineage
but provide some T cell-related results in the Supplemen-
tal Data. In animals carrying one copy of the mir150-EGFP
Tg or mir150 Tg allele, the numbers of mature lympho-
cytes in the spleen were reduced at young age and be-
came comparable to those of littermate controls only by
6–8 weeks (Figure 4F and Figure S5A). In mice carrying
two copies of the mir150-EGFP Tg allele, the numbers of
mature T cells were reduced at young age and became
comparable to control levels at the age of 18–41 weeks
(Figures S5A and S5B), whereas B cell numbers, espe-
cially B1 cell numbers, stayed lower than control levels
during the same age range (Figures 4F and 4G). mir150
Tg/Tg mice were severely lymphopenic over the entire
time of observation (Figure 4F and Figure S5A). Analysis
of bone marrow by flow cytometry revealed a significantCell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc. 151
Figure 4. Ectopic MiR-150 Expression Impairs B Cell Development
(A) Scheme ofRosa26 locus targeting. The mir150 genomic DNA includes the mir150 stem loop, a 136 bp 50 flanking sequence, and a 130 bp 30 flank-
ing sequence. Both deleter-Cre and deleter-Flpe express their respective recombinases early during embryogenesis and delete in the germline. For
both mir150-EGFP Tg and mir150 Tg, the CAG promoter drives transcription in all cells/tissues.152 Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc.
block early during B cell development, at the pro- to pre-B
cell transition, in both young and old animals alike
(Figure 4H and data not shown). A less pronounced block
was apparent in the T cell lineage, at the double-negative 3
(DN3) to double-negative 4 (DN4) transition (Figure S5C).
These results are in partial agreement with a study that ap-
peared when this paper was written up, in which retroviral
overexpression of miR-150 in hematopoietic progenitors
led to a block of B, but not T, cell development (Zhou
et al., 2007). Complete deletion of c-Myb in B and T cell
lineages causes more severe developmental blocks at
exactly the same transition points (Bender et al., 2004;
Thomas et al., 2005), suggesting that the block in miR-
150 transgenic mice is due to reduced c-Myb protein
levels in lymphocyte progenitors. That this is indeed the
case is experimentally verified further below (see Fig-
ure 6). The gradual increase of peripheral T and B cell num-
bers in the mutant animals likely reflects the accumula-
tion of long-lived T and B cells over time, as it is often
observed in mice in which lymphocyte development is
compromised.
Ectopic MiR-150 Expression Increases Cell Death
of In Vitro-Cultured Pro-B Cells
To test whether the phenotype seen in the mir150 trans-
genic mice is due to a lymphocyte autonomous mecha-
nism and to better understand the block at the pro- to
pre-B transition in these animals, we used an in vitro
pro-B cell culture system, in which pro-B cells proliferate
in an IL-7 and stroma cell-dependent manner (Rolink
et al., 1991). B lineage cells from the bone marrow were
purified by magnetic cell sorting (MACS) using magnetic
beads coated with anti-CD19 or B220 antibodies and cul-
tured for up to 6 days. We observed a reduced cell output
from the mir150-EGFP Tg/Tg cultures, while the cellular
composition of the output of these cultures was compara-
ble to that of wild-type cell cultures (Figures S6A and S6B).
PKH26 Red labeling of transgenic and wild-type cells re-
vealed no major difference in cell proliferation (Figure S6C).
Staining with propidium iodide (PI), however, demon-
strated an increase in the sub-G0 population in the
mir150-EGFP Tg/Tg cultures, suggesting that increased
cell death caused the reduced cell output (Figure 5A).
We also tested mir150 Tg/Tg mice by culturing FACS-
sorted pro-B cells, to avoid heterogeneity among inputcells. We again detected a markedly decreased output
of cells from the mir150 Tg/Tg cultures compared to the
controls, accompanied by a decrease in cell viability as
determined by the Guava ViaCount assay (85% for wild-
type versus 55% for mir150 Tg/Tg cultures) (Figure 5B).
MiR-150 expression in the bulk-cultured mir150-EGFP
Tg/Tg pro-B cells was 63% of that in splenic B cells, lead-
ing to a reduction of c-Myb protein by 34% compared to
bulk-cultured wild-type pro-B cells (Figure 5C).
Small Changes of c-Myb Protein Levels
Have Severe Functional Consequences
Is a 30%–35% reduction of c-Myb protein levels sufficient
to cause the dramatic phenotype seen in themir150 trans-
genic mice? We analyzed heterozygous c-Myb knockout
mice to address this question. In thymocytes from these
animals, the c-Myb protein level was reduced by about
26% (Figures 6A and 6B). Strikingly, the heterozygous mu-
tant mice displayed a marked reduction of the numbers of
mature B cells in the spleen at young age (Figure 6C), and
a block at the pro- to pre-B transition as had been ob-
served in mir150 Tg/Tg mice (Figure 6D). This develop-
mental block had not been apparent in our original study
(Thomas et al., 2005), likely due to the mixed genetic back-
ground of the experimental animals used in those experi-
ments. A reduction of pre-B cell numbers in the bone mar-
row persisted in the animals over time (Figure S8), so that
the normalization of lymphocyte numbers in the peripheral
immune system at older age is likely due to the accumula-
tion of long-lived mature cells. Furthermore, B1 cells in
these mice were markedly reduced in the spleen and peri-
toneal cavity (Figures 6E and 6F). These results indicate
that lymphocyte development is exquisitely sensitive to
small changes of c-Myb protein levels, similar to the
ones brought about by ectopically expressed miR-150 in
the transgenic animals. Therefore, in a first approximation,
the phenotype observed in the mir150 transgenic mice
can be explained by the control of c-Myb expression by
this miRNA, and this could equally be true for the B1 cell
expansion and enhanced B cell response in the mir150
knockout mice. This is reminiscent of observations that
small changes in the cellular concentrations of key tran-
scription factors have severe consequences on the line-
age commitment of early hematopoietic progenitors
(Laslo et al., 2006).(B) Ectopic miR-150 expression in tissues of mir150-EGFP Tg/Tg mice was determined by northern blot. The miR-150/U6 ratio in wild-type CD4 T
cells was arbitrarily set at 1.
(C) Ectopic miR-150 expression in thymocytes was determined by northern blot. Note that the ectopic expression level was below the endogenous
expression level in naive CD4 T cells, whose miR-150/U6 ratio was arbitrarily set at 1.
(D) Ectopic miR-150 expression repressed c-Myb protein levels in thymocytes. c-Myb and b-actin levels were determined by western blot, and the
c-Myb/b-actin ratio in control thymocytes was arbitrarily set at 1.
(E) Average miR-150/U6 and c-Myb/b-actin ratios in thymocytes of mice of indicated genotypes. Numbers above (upper panel) or inside (lower panel)
bars indicate the numbers of mice examined. Mice were examined at the age of 4–41 weeks, and the miR-150 and c-Myb levels didn’t change over
age. Data are presented as mean ± SD.
(F) B cell numbers in the spleen of 3- to 12-week-old mice ectopically expressing miR-150 were reduced. Each dot represents one mouse examined.
(G) Cell numbers of B cell subsets in the spleen and peritoneal cavity of 18- to 41-week-old mice of indicated genotypes. Bars indicate mean values.
(H) The pro- to pre-B cell transition in the bone marrow (BM) of mice ectopically expressing miR-150 was impaired. Five mice per genotype were
analyzed at the age of 5–12 weeks, with similar block at pro- to pre-B transition. Older mir150 Tg/Tg mice exhibited more immature and mature B
cells in the bone marrow than the 5.4-week-old mir150 Tg/Tg mouse shown in this figure.Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc. 153
Figure 5. Ectopic MiR-150 Expression Increases Cell Death of In Vitro-Cultured Pro-B Cells
(A) Cell-cycle analysis of in vitro-cultured bone marrow pro-B cells. Note that the mir150-EGFP Tg/Tg culture contained more dead cells (Sub-G0).
This analysis was performed for in vitro pro-B culture experiment 1 and 3 listed in Figure S6A, with similar results.
(B) Growth curve of FACS-sorted bone marrow pro-B cells (B220+cKit+CD25) in in vitro culture. Note the dose-dependent reduction of cell numbers
for pro-B cells expressing miR-150. Two mice per genotype were examined.
(C) Expression of miR-150 and c-Myb in in vitro-cultured pro-B cells as determined by northern and western blots, respectively. The miR-150/U6 ratio
in splenic B cells and the c-Myb/b-actin ratio in control pro-B cells were arbitrarily set at 1. This experiment was performed for in vitro pro-B culture
experiment 1 and 3 listed in Figure S6A, with similar results.DISCUSSION
In the present work we address the function of a miRNA,
which is stage specifically expressed in lymphocyte de-
velopment, by genetically manipulating its expression in
gain- and loss-of-function experiments and by genetically
identifying one of its bioinformatically predicted targets as
a true, functionally critical target in the in vivo context. The
results of the reporter assays and the enhanced c-Myb154 Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc.upregulation upon activation of mir150-deficient lympho-
cytes established that miR-150 directly regulates c-Myb
protein levels through two conserved miR-150 binding
sites in the 30UTR of the c-Myb mRNA. That miR-150 in-
deed controls c-Myb levels in vivo was corroborated in ex-
periments in which the miRNA was ectopically expressed
at moderate levels in B cell progenitors, where it is nor-
mally not expressed, whereas c-Myb expression is high.
This led to a miR-150 dose-dependent downregulation
of c-Myb levels, and resulted in a partial block of B cell de-
velopment and a reduction in B1 cell numbers. A similar
phenotype was obtained when c-Myb levels were similarly
reduced by partial ablation of c-Myb, in heterozygous
c-Myb mutants. This result demonstrated that the partial
block of B cell development through miR-150 expression
was indeed due to c-Myb downregulation in a first approx-
imation. The phenotype of miR-150 knockout mice, which
we also generated, is compatible with the notion that
c-Myb is the major target of miR-150 also in normal phys-
iology. Here this miRNA is predominantly expressed in
mature lymphocytes. Upon its genetic ablation, B1 cells,
one of the subsets of mature B cells, expand in spleen
and peritoneal cavity, a phenotype directly opposed to
the B1 cell ablation seen upon B cell-specific c-Myb dele-
tion (Thomas et al., 2005). MiR-150 ablation also strikingly
affected antibody production. Significantly higher levels of
immunoglobulins of various classes were present in the
blood of the mutant animals compared to controls. That
this is partially connected to the B1 cell expansion in these
mice is supported by the finding that the most drastic in-
crease was seen for IgA, an isotype to whose expression
B1 cells preferentially switch (Kaminski and Stavnezer,
2006). However, the loss of miR-150 also enhances the
antibody response to T cell-dependent antigen, which is
classically mediated by B2 cells. We speculate that this
may be due to the enhanced expression of c-Myb in those
cells upon activation. This is supported by the increased
expression levels of Bcl2, a direct c-Myb target gene,
and the reduction of cell death that we have observed in
activated mir150/ B cells upon IgM crosslinking.
Our results do not exclude the possibility that other miR-
150 target genes may also contribute to the phenotypes of
mir150/ and miR-150 transgenic mice. We have exam-
ined the expression levels of Foxp1 and ZFP91, two
predicted miR-150 target genes that are potentially func-
tionally relevant, in mir150/ and miR-150 transgenic
lymphocytes. Foxp1 is an essential regulator of early B
cell development (Hu et al., 2006), and ZFP91 is implicated
in cell proliferation and survival (Unoki et al., 2003). The
expression levels of these two proteins were, however,
not affected by the absence or ectopic expression of
miR-150 in resting and activated B cells (Figure S9). Still,
targeted mutagenesis of the miR-150 binding sites in the
c-Myb 30UTR will be ultimately required to determine to
what extent contributions of target genes other than
c-Myb have to be taken into account in order to fully un-
derstand the mutant phenotypes.
Our study suggests a few basic principles of the rela-
tionship between miRNAs and their target genes. First,
our results suggest that the cellular concentration of a
miRNA dictates the degree to which its target genes are
affected, and is therefore of key importance in miRNA-
mediated control. Second, our results highlight the biolog-
ical relevance of this control mechanism, even when it
modulates the concentration of a target protein over a rel-
atively narrow range, as in the present example of a basic
transcription factor in the hematopoietic system. The ex-quisite, quantitatively graded effect on c-Myb expression
observed upon graded, moderate expression of miR-150
in an in vivo setting, together with its severe physiological
consequences, may be just one example of an intra-
cellular protein exerting its function over a narrow concen-
tration range and being controlled by relatively small
changes in the cellular concentration of a miRNA. Indeed,
miRNAs may have evolved to exert their function in such
contexts, whose analysis requires precise control of
miRNA and target gene expression. Third, while bioinfor-
matics analyses predict hundreds of target genes for
each miRNA (Rajewsky, 2006), only a few of these may
represent targets with a significant biological function for
a particular biological process (Lee et al., 1993; Wightman
et al., 1993). It is therefore possible that gain- and loss-of-
function mutations of individual miRNAs can result in phe-
notypes as distinct as they are seen when protein-coding
genes are mutated in similar ways. Indeed, we have seen
clear phenotypes in each of three miRNA mutants that we
have generated to date (Thai et al., 2007; the present work;
and C.X., L. Srinivasan, D.P.C., H.C.P., Joel M. Hender-
son, Jeffrey L. Kutok, and K.R., unpublished data). It is
also noteworthy that miR-150 ectopic expression in non-
hematopoietic cell lineages in our transgenic mice does
not seem to have any obvious adverse physiological ef-
fects, although the CAG promoter at the Rosa26 locus
drives its expression in most tissues of the mouse. Thus,
miRNA-mediated control can also display specificity in
terms of functional restriction to a particular differentiation
pathway. Finally, our study confirms in an in vivo setting
that a perfect match at nucleotide positions 1–8 between
a miRNA and its binding site, the evolutionary conserva-
tion of the site, and the number of sites are good indicators
of function, as proposed in previous publications on target
gene predictions.
EXPERIMENTAL PROCEDURES
Mice and Cells
To generate mir150/ mice, we inserted an frt-flanked pGK-Neo cas-
sette 468 bp upstream of the miR-150 stem loop, with one loxP site
placed immediately upstream of the pGK-Neo cassette and the other
loxP site placed 146 bp downstream of the miR-150 stem loop. Gene
targeting was conducted according to established protocols in the lab-
oratory, using the Bruce 4 ES cells. Mice were generated by injecting
targeted ES cells into B6 albino blastocysts and maintained on
a pure C57BL/6 background. Mice carrying the targeted allele were
bred with deleter-Cre mice (Schwenk et al., 1995), which deleted the
loxP site-flanked 679 bp miR-150 coding genomic region and the
frt-flanked pGK-Neo cassette early during embryogenesis, including
the germline. The resulting mice were then bred to obtain mir150
homozygous mutants (mir150/ mice).
To generate mir150 transgenic mice, we cloned a miR-150-coding
genomic DNA fragment into a modified version of pROSA26-1 as pre-
viously described (Sasaki et al., 2006), preceded by the CAG promoter
and a loxP-flanked Neo-STOP cassette, followed by an frt-flanked
IRES-EGFP cassette and a polyadenylation signal (pA). Gene targeting
was conducted according to established protocols in the laboratory,
using the ARF1 R19 ES cells (Artemis Pharmaceuticals, Germany).
Mice were generated by injecting targeted ES cells into tetraploid blas-
tocysts and maintained on a mixed C57BL/6x129 background. MiceCell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc. 155
Figure 6. Impaired B Cell Development and Reduced B1 Cell Numbers in c-Myb Heterozygous Mice
(A) c-Myb protein levels in c-Myb+/ mice were determined by western blot. The highest c-Myb/b-actin ratio among wild-type mice was arbitrarily set
at 1.
(B) Average c-Myb protein levels in thymocytes of c-Myb+/ mice. The average c-Myb/b-actin ratio in c-Myb+/+ thymocytes was arbitrarily set at 1.
Numbers inside bars indicate the numbers of mice examined. Two mice per genotype were analyzed at 10 weeks (shown in [A]), and the other two per
genotype were analyzed at 26 days with similar results. Data are presented as mean ± SD.
(C) Reduced B cell numbers in the spleen of 2-week-old c-Myb+/ mice. Each dot represents one mouse examined. Bars indicate mean values.156 Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc.
carrying the targeted allele were bred with deleter-Cre mice (Schwenk
et al., 1995), which deleted the Neo-STOP cassette early during em-
bryogenesis, including the germline. The resulting mice were then
bred with deleter-Flpe mice (Rodriguez et al., 2000), which deleted
the IRES-EGFP cassette early during embryogenesis, including the
germline, too. The offspring from the previous breeding were further
bred between siblings. The deletions of Neo-STOP and/or IRES-
EGFP are complete in all experimental mice, as examined by PCR
on tail DNA samples.
The generation of c-Myb+/ mice was reported previously (Bender
et al., 2004), and these mice are maintained on a pure C57BL/6 back-
ground.
For determining the expression patterns of miR-150 and c-Myb
during lymphocyte development, the following cells were used: pro-
B, fetal liver pro-B cell culture from invPE/JHT mice; pre-B, Abelson
virus-transformed pre-B cells from wild-type mice; splenic B, MACS-
purified CD19+ splenocytes from wild-type C57BL/6 mice; DN and
DP thymocytes, total thymocytes from Rag2/ mice and TCR Ca/
mice, respectively; and CD4 and CD8 T cells, purified from OTII;TCR
Ca/ mice and P14 Tg;TCR Ca/ mice, respectively. All mouse
experiments were approved by the Harvard University Institutional
Animal Care and Use Committee and by the CBR Institute for Biomed-
ical Research.
Western Blot and Northern Blot
These were conducted as previously described (Monticelli et al., 2005;
Sasaki et al., 2006). The anti-Myb monoclonal antibody clone 1-1
(Upstate), anti-mouse Bcl2 monoclonal antibody clone 3F11 (BD Phar-
Mingen), rabbit anti-ZFP91 polyclonal antibody (Abcam), and anti-b-
actin monoclonal antibody clone AC-74 (Sigma) were used for western
blot. Foxp1 antibody was previously described (Hu et al., 2006). DNA
oligonucleotides antisense to mature miRNAs were used as probes
to detect miRNAs in all northern blots. For quantifying western blots,
we used a Fujifilm LAS-3000 imaging system, whose imaging sensor
is a high-sensitivity, peltier-cooled chip, recording a maximum of 3.2
megapixels. The sensor collects 16 bits per pixel and this provides
a large linear range (four orders of magnitude). We used a Molecular
Dynamics Storm860 PhosphorImager to quantify all our northern blots.
A PhosphorImager is based on imaging plates that replace normal
X-ray film in autoradiographic measurements. An imaging plate con-
sists of a thin layer of special crystals doped with lanthanides. Radio-
active radiation excites the crystals, and a latent image of the sample is
formed on the plate. The image is read into the computer by scanning
the plate with a red laser beam using a dual-optical fiber. The red light
further excites the pre-excited phosphor particles, causing emission of
blue light. The intensity of this emission is measured with a photomul-
tiplier and used to construct an image of the sample. PhosphorImager
systems are linear over a wide dynamic range of signal intensity.
Flow Cytometry
All flow cytometry analyses of mir150 knockout and mir150 transgenic
mice were performed on a Becton Dickinson FACSCalibur at the CBR
Institute for Biomedical Research, whereas all analyses of c-Myb mice
were performed at the flow cytometry facility at the Department of
Microbiology, University of Virginia Health System. Data were acquired
uncompensated, then compensated and analyzed with the FlowJo
analysis program (Tree Star Inc.).
In Vitro Lymphocyte Activation
For determining miR-150 and c-Myb expression levels, B cells from
both spleen and peripheral lymph nodes were MACS purified and ac-tivated in vitro at a density of 0.5–13 106 cells/ml with 10 mg/ml of goat
anti-mouse IgM, m chain-specific F(ab0)2 fragment (Jackson Immunor-
esearch), 0.64 mg/ml of CpG (ODN 1826, Invitrogen), 20 mg/ml of LPS
(Sigma), 20 mg/ml of LPS plus 25 ng/ml of recombinant mouse IL-4
(R&D), or 20 mg/ml of LPS plus 2 mg/ml of anti-CD40 (1C10, eBio-
science). CD4 T cells from both spleen and peripheral lymph nodes
were MACS purified and activated in vitro at a density of 5 3 105
cells/ml with 0.25 mg/ml of anti-CD3 (clone 145_2C11, eBioscience)
plus 2 mg/ml of anti-CD28 (clone 37.51, eBioscience) in the presence
of 20 ng/ml of recombinant murine IL-2 (Peprotech), in a flask coated
with 0.3 mg/ml of goat anti-hamster (Jackson Immunoresearch). Acti-
vated lymphocytes were harvested at the indicated time points for
western blot and northern blot analyses.
Proliferation Analysis
MACS-purified B cells and CD4 T cells were labeled with 1 nM CFSE
for 10 min at 37C in 5% CO2, followed by two washes with culture me-
dium. Labeled lymphocytes were activated with indicated stimuli as
described above. CFSE fluorescence intensity was determined by
flow cytometry at the indicated time points, and data were analyzed
by using the proliferation platform of the FlowJo software (Tree Star
Inc.).
MACS-enriched bone marrow B lineage cells were labeled with
PKH26 using the PKH26 Red Fluorescent Cell Linker Kit (Sigma), ac-
cording to the manufacturer’s instructions. Labeled cells were put
into the pro-B cell culture system as described below. PKH26 fluores-
cence intensity was determined by flow cytometry at the indicated
time points.
In Vitro Class Switching Assay
MACS-purified B cells were plated at a concentration of 13 106 cells/
ml in 24-well plates and activated for 4 days in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal calf serum,
L-glutamine, penicillin-streptomycin, nonessential amino acids, so-
dium pyruvate, HEPES, and 2-mercaptoethanol (Invitrogen) with indi-
cated stimuli to induce class switching to specific isotypes. For IgG1
class switch, cells were stimulated in the presence of 2 mg/ml of
anti-CD40 (Clone HM-40-3, eBioscience) plus 25 ng/ml of mouse re-
combinant IL-4 (Peprotech); for IgA class switch, cells were stimulated
in the presence of 25 mg/ml of LPS (Sigma) plus 1 ng/ml of TGFb1; and
for IgG3 class-switch, cells were cultured simply in the presence of
25 mg/ml of LPS. After 4 days, cells were stained with the following an-
tibodies: goat anti-mouse IgG1, goat anti-mouse IgA, or goat anti-
mouse IgG3 (Southern Biotech). Class switching was monitored by
flow cytometry.
Immunization and ELISA
To determine steady-state serum immunoglobulin levels, unimmu-
nized mice were bled at the age of 8–10 weeks. For T-dependent
immune response, 9-week-old mice were immunized with 5 mg of
NP36-CCG (4-hydroxy-3-nitrophenylacetyl chicken g-globulin, Bio-
searchTechnologies) precipitated in Imject Alum (Pierce Biotechnol-
ogy) intraperitoneally. Mice were bled at indicated time points. Serum
samples were analyzed by ELISA with coating and detection anti-
bodies purchased from Southern Biotech (Birmingham, AL) and Bio-
search Technologies.
Pro-B Cell Culture
The in vitro pro-B cell culture was performed as previously reported
(Rolink et al., 1991). In short, stroma cells (ST-2 cells) were grown to
confluency, treated with 10 mg/ml mitomycin C for 2–3 hr. Cells were(D) The pro- to pre-B cell transition in the bone marrow (BM) of c-Myb+/ mice was impaired. Five mice per genotype were analyzed at the age of
2 weeks, with similar results.
(E and F) Reduced B1 cells in the spleen and peritoneal cavity of c-Myb+/ mice, examined at the age of 10–16 weeks. Each dot in (F) represents one
mouse examined. Bars indicate mean values.Cell 131, 146–159, October 5, 2007 ª2007 Elsevier Inc. 157
washed twice with PBS and incubated with pro-B cell medium before
use. B lineage cells were enriched by B220- or CD19-MACS from total
bone marrow cells after red blood cell lysis and plated on mitomycin
C-treated stroma cells in pro-B cell medium containing 5 ng/ml re-
combinant human IL-7 purchased from National Institute of Health.
Reporter Assay
HEK293T cells were plated into 12-well plates at 3–4 3 105 cells/well
24 hr before transfection. 0.2 mg psiCHECK2 (Promega) reporter plas-
mid containing the c-Myb 30UTR or its mutants and 0.8 mg miRNA-
expressing pCXN2 plasmid were cotransfected into each well by using
the Fugene 6 transfection reagent (Roche) in triplicates. Luciferase as-
says were performed 24 hr after transfection by using the Dual-Lucif-
erase Reporter Assay System (Promega) on a Berthold AutoLumat
LB953 rack luminometer.
Cell-Cycle Analysis
Cultured cells were washed in protein-free PBS, pelleted, and resus-
pended in 500 ml cold PBS. One milliliter cold 95% ethanol was added
to cells while gently vortexing, followed by a 2 hr incubation on ice. The
cells were washed with PBS, resuspended in 200 ml 0.5 mg/ml RNase
A, and incubated at 37C for 20 min. Subsequently, 200 ml of 40 mg/ml
propidium iodide was added, and the cells were incubated at room
temperature in the dark for 30 min. The samples were analyzed for
DNA content by flow cytometry as described above.
Statistics
P values were determined by applying Student’s two-tailed t test for in-
dependent samples, assuming equal variances on all experimental
data sets.
Supplemental Data
Supplemental Data include nine figures and two tables and can be
found with this article online at http://www.cell.com/cgi/content/full/
131/1/146/DC1/.
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